Evidence map›Paper›PMID 29307084›Full record

ReviewNeurochemical research2019

GluN2B Subunit of the NMDA Receptor: The Keystone of the Effects of Alcohol During Neurodevelopment.

Mickaël Naassila, Olivier Pierrefiche

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Discovery of GluN2A subtype-selectiveActa pharmaceutica Sinica. B · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Projection-Specific Potentiation of Ventral Pallidal Glutamatergic Outputs after Abstinence from Cocaine.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mickaël NaassilaUniversité de Picardie Jules Verne, INSERM U1247 Research Group on Alcohol & Pharmacodependences (GRAP) - CURS, Chemin du Thil, 80025, Amiens Cedex 1, France.ORCID http://orcid.org/0000-0002-9788-0918
Olivier PierreficheUniversité de Picardie Jules Verne, INSERM U1247 Research Group on Alcohol & Pharmacodependences (GRAP) - CURS, Chemin du Thil, 80025, Amiens Cedex 1, France. olivier.pierrefiche@u-picardie.fr.ORCID http://orcid.org/0000-0003-1427-9332

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glutamatergic system plays a central role in both the acute and chronic effects of ethanol. Among all the glutamate receptors the ionotropic NMDA receptors are crucial because of their role in synaptic plasticity. A large body of evidences suggests that short-term and long-term effects of ethanol may change synaptic plasticity via an alteration of the expression of the GluN2B subunit, one constitutive element of the NMDA receptor. The present review is focusing on the role of the GluN2B subunit after ethanol exposure during early life (in utero and adolescence) and also at adulthood. The roles of other NMDA subunits are also discussed in the context of the increasing evidence that the ratio of the different subunits, such as GluN2A-to-GluN2B, seems to better reflect the effects of ethanol and to explain how ethanol exposure can have short lasting and long lasting effects on synaptic plasticity, cognitive processes and some of the ethanol-related behaviors.

Indexed as

Alcohol DrinkingAnimalsBrainEthanolFemaleHumansNeurodevelopmental DisordersPregnancyPrenatal Exposure Delayed EffectsProtein SubunitsReceptors, N-Methyl-D-AspartateEthanolNR2B NMDA receptorProtein SubunitsReceptors, N-Methyl-D-AspartateAdolescenceAlcoholGLUN2 subunitGlutamateIn uteroNMDA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.